Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
80.72
Dollar change
+0.46
Percentage change
0.57
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.K. Return% 1Y52.41% Total Holdings2 Perf Week-2.52%
SponsorPrecidian ETF Type Tagssingle-asset Return% 3Y- AUM802.64K Perf Month13.80%
Fund Family Bond Type TagsGSK Return% 5Y- NAV/sh Perf Quarter16.92%
Index- Average Maturity Tagshedge-currency Return% 10Y 52W High82.82 -2.54% Perf Half Y48.51%
Index Weighting Commodity Type Tags- Return% SI 52W Low48.14 67.67% Perf YTD18.35%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.70% 0.71% Perf Year50.40%
Dividend TTM0.79 (0.97%) ESG Type Tags- Flows% 3M0.00% ATR (14)1.34 Perf 3Y-
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)72.33 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta-0.23 Perf 10Y-
Expense0.19% Growth/Value SMA209.55% Flows% 3Y Rel Volume1.18 Prev Close80.26
Inverse/Leveraged Market Cap SMA5013.93% Flows% 5Y Avg Volume0.28K Price80.72
IPOJan 07, 2025 Option/ShortNo / Yes SMA20032.75% Trades Volume326 Change0.57%
GSK plc ADRhedged seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of GSK plc in its local market. The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of GSK plc (the "Company"). The series will not invest directly in the company. The fund is non-diversified.